4 recruiting, 4 unknown, 3 completed, 3 not yet recruiting. 4 Not applicable, 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Recruiting 2, Unknown 2 |
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Alcohol-Related Liver Disease: new trials by email Literature Review of Alcohol-Related Liver Disease trials Research Report on Alcohol-Related Liver Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Misocholic Tablets for Non-Viral Elevated Liver Enzymes Misocholic Tab, Placebo, Silymarin (Silybum marianum) - Alcohol-Related Liver Disease, Drug-Induced Liver Injury | Phase 3 | Not yet recruiting | Hanoi Medical University | 60 | 2026-09-15 | 2026-09-22 |
| Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients ENGAGE-ALD Application (APP), Treatment Facilitation bundle, Enhanced Usual Care - Alcohol-related Liver Disease, Liver Diseases | Not applicable | Recruiting | Henry Ford Health System | 268 | 2026-01-28 | 2026-02-03 |
| A Study to Predict Recompensation in Patients With Decompensated Cirrhosis Using Spleen Stiffness and Simple Blood Tests Decompensated Cirrhosis, Hepatitis B Virus (HBV) Infection | Not yet recruiting | Beijing Friendship Hospital | 735 | 2025-07-15 | 2025-07-25 | |
| Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease HepQuant DuO Test - Alcoholic Hepatitis, Alcohol-related Liver Disease | Recruiting | HepQuant, LLC | 40 | 2025-06-10 | 2026-09-16 | |
| Genetic Polymorphisms Associated With the Risk of Pancreatitis in Patients With Alcohol Related Cirrhosis. Alcohol-related Liver Disease | Not yet recruiting | Institute of Liver and Biliary Sciences, India | 150 | 2025-01-25 | 2025-01-22 | |
| Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease Connections App - Alcohol Use Disorder, Alcohol-related Liver Disease | Not applicable | Recruiting | University of Wisconsin, Madison | 298 | 2024-06-01 | 2026-07-31 |
| Effects of NNC0194-0499, Cagrilintide, and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Use in People With Alcohol-related Liver Disease NNC0194-0499, Semaglutide, NNC0194-0499 placebo - Alcohol-related Liver Disease | Phase 2 | Completed | Novo Nordisk A/S | 270 | 2024-05-20 | 2026-03-12 |
| Study of the Drivers of Late Diagnosis of Alcohol Related Diseases, Alone or in Combination With Metabolic Dysfunconal Associated Fatty Liver Disease, Implementation and Evaluation of Itnerventions to Reduce Its Burden. brief intervention - Alcohol-related Liver Disease, Alcohol Use Disorder | Not applicable | Unknown | Hospital Universitari Vall d'Hebron Research Institute | 350 | 2023-02-02 | 2024-05-07 |
| Contingency Management to Incentivise Treatment Adherence in Alcohol-related Liver Disease Contingency management - Alcohol-related Liver Disease | Not applicable | Unknown | King's College Hospital NHS Trust | 30 | 2023-01-01 | 2024-02-07 |
| CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome Liver biopsy - Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis | Recruiting | Institut National de la Santé Et de la Recherche Médicale, France | 710 | 2022-12-06 | 2026-04-16 | |
| Impact of COVID-19 Outbreak on the Alcohol Consumption in Patients With Alcohol-related Liver Disease (ICoLD) Study questionnaire - Alcohol-related Liver Disease, Alcohol Dependence | Unknown | King's College Hospital NHS Trust | 200 | 2020-10-08 | 2021-05-10 | |
| Acamprosate Safe to Use in Individuals With Liver Disease. Acomprosate - Alcohol-related Liver Disease | Phase 2 | Completed | Mayo Clinic | 12 | 2020-09-21 | 2022-12-20 |
| Investigating Myosteatosis in Steatotic Liver Diseases Alcohol-related Liver Disease, Metabolic Dysfunction Associated Steatotic Liver Disease | Unknown | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 100 | 2020-06-22 | 2024-07-23 | |
| Alcohol Biomarkers in Post-Liver Transplant Patients Alcohol-related Liver Disease | Completed | Northwestern University | 214 | 2013-03-01 | 2023-02-24 |
Alcoholism (5) · Non-alcoholic Fatty Liver Disease (2) · Carcinoma, Hepatocellular (1) · Chemical and Drug Induced Liver Injury (1) · Hepatitis B (1) · Hepatitis, Alcoholic (1) · Hypertension, Portal (1) · Infections (1) · Liver Cirrhosis (1) · Liver Diseases (1) · Treatment Adherence and Compliance (1)
Chemically-Induced Disorders (7) · Alcohol-Related Disorders (6) · Substance-Related Disorders (6) · Digestive System Diseases (5) · Mental Disorders (5) · Liver Diseases (4) · Fatty Liver (2) · Hepatitis (2) · Adenocarcinoma (1) · Alcohol-Induced Disorders (1) · Behavior (1) · Blood-Borne Infections (1) · Carcinoma (1) · Communicable Diseases (1) · DNA Virus Infections (1)
Crisis Intervention (1) · Silymarin (1) · cagrilintide (1) · milk-thistle extract (1) · semaglutide (1)
King's College Hospital NHS Trust (2) · Beijing Friendship Hospital (1) · Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1) · Hanoi Medical University (1) · Henry Ford Health System (1) · HepQuant, LLC (1) · Hospital Universitari Vall d'Hebron Research Institute (1) · Institut National de la Santé Et de la Recherche Médicale, France (1) · Institute of Liver and Biliary Sciences, India (1) · Mayo Clinic (1) · Northwestern University (1) · Novo Nordisk A/S (1) · University of Wisconsin, Madison (1)
United States (6) · France (2) · Spain (2) · United Kingdom (2) · Australia (1) · Belgium (1) · Bulgaria (1) · Canada (1) · China (1) · Czechia (1) · Denmark (1) · Germany (1) · Greece (1) · India (1) · Italy (1)
Andrew Quanbeck, PhD (1) · Colin Drummond (1) · Douglas A Simonetto (1) · Hong You, Prof. (1) · Jessica Mellinger, MD, MSc (1) · Michael F Fleming, MD, MPH (1) · Nicolas Lanthier, MD, PhD (1)
PMID 40136257, PMID 41127673, PMID 42214070
2023 (1), R01AA030470 (1), R01AA030748 (1)